Skip to main content
NIH funding notice RFA-AI-22-046

Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)

Closed on November 8, 2022.

Posted
July 20, 2022
Close date
November 8, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,171,776 in first-year total cost, median $573,972.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 MFH-M (M1)]7

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY2
  2. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
  3. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  4. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
  5. TUFTS UNIVERSITY BOSTON1
Competing awards under RFA-AI-22-046 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Discovery of early immunologic biomarkers for risk of PTLDS through machine learning-assisted broad temporal profiling of humoral immune response1R01AI178727-01WOODBURY, NEAL WALTERARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ$649,935ZAI1
2023Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery1R01AI178713-01TAL, MICHAL CASPIMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$635,954ZAI1
2023Determinants of Post-Treatment Phenotypes in Lyme Disease1R01AI178726-01AUCOTT, JOHNJOHNS HOPKINS UNIVERSITY, MD$635,101ZAI1
2023Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms1R01AI178774-01MARVEL, CHERIE LJOHNS HOPKINS UNIVERSITY, MD$573,972ZAI1
2023The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts1R01AI178711-01JUTRAS, BRANDON LYONVIRGINIA POLYTECHNIC INST AND ST UNIV, VA$561,872ZAI1
2023Genetic basis for persistence of Borrelia burgdorferi1R01AI178718-01TOKARZ, RAFALCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$559,770ZAI1
2023Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome1R01AI178725-01HU, LINDEN TTUFTS UNIVERSITY BOSTON, MA$555,172ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.